.svg){kind=small}
Oct-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Canna Clinicals has shown consistent performance in the Tincture & Sublingual category in New York, maintaining a steady presence in the top 10 throughout the past few months. The brand held the 6th position in July and August, briefly dropped to 7th in September, before reclaiming the 6th spot in October. This stability indicates a strong foothold in the New York market, suggesting that consumers have a reliable demand for their products. The sales figures also reflect a positive trajectory, with a notable increase from August to October, highlighting an upward trend in consumer interest and market penetration.
However, the performance of Canna Clinicals in other states and categories is not as prominent, as they do not appear in the top 30 rankings for those areas. This absence could be seen as a limitation in their market reach or a potential area for growth, depending on the brand's strategic goals. The lack of presence in other regions might suggest that their product offerings or marketing strategies are more tailored to the New York market, or that they face stronger competition elsewhere. Understanding the dynamics in these other states could provide further insights into where Canna Clinicals might focus future efforts to expand their brand presence.
Competitive Landscape
In the competitive landscape of the Tincture & Sublingual category in New York, Canna Clinicals has experienced fluctuations in its market position over the past few months. Starting in July 2024, Canna Clinicals held the 6th rank, maintaining this position in August, but slipped to 7th in September before reclaiming the 6th spot in October. This movement indicates a dynamic market environment where Canna Clinicals faces stiff competition. Notably, OMO - Open Minded Organics consistently held the 4th position, showcasing a stable and strong market presence. Meanwhile, Veterans Choice Creations (VCC) maintained a steady 5th rank, indicating robust sales performance. Harney Brothers Cannabis showed some volatility, ranking 7th in August, moving up to 6th in September, and then back to 7th in October. These shifts highlight the competitive pressures Canna Clinicals faces, as it strives to improve its sales and rank amidst strong contenders in the New York market.
Notable Products
In October 2024, the CBD/THC 1:10 Max Strength Tincture maintained its position as the top-performing product for Canna Clinicals, with sales reaching 255 units, showing a consistent trend as it held the number one rank since July. The Max Strength Capsules 10-Pack also sustained its rank at number two for the fourth consecutive month, demonstrating steady demand. The CBD/THC/CBG 1:1:1 Relief Complex Capsules remained third in the rankings from August through October, indicating a gradual acceptance in the market. Notably, the CBD/THC/CBN 1:1:1 Sleep Complex Capsules, which ranked third in July, did not appear in the top rankings from August onwards. Overall, the rankings for October highlight a stable market preference for the top two products, with some shifts observed in the lower ranks.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
